{
    "clinical_study": {
        "@rank": "9949", 
        "arm_group": [
            {
                "arm_group_label": "Intervention group", 
                "arm_group_type": "Active Comparator", 
                "description": "IV acetaminophen: 1000mg IV q 8 hrs (scheduled) until: a) tolerating PO and IV saline-locked or b) 48 hours reached on medication"
            }, 
            {
                "arm_group_label": "Placebo Group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "IV Normal Saline: 100ml IV q 8 hrs (scheduled) until: a) tolerating PO and IV saline-locked or b) 48 hours reached on medication"
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient\n      pain.\n\n      To assess the effect of an intravenous nonnarcotic pain medication on patient sedation\n      levels in neurocritically ill patients.\n\n      To assess the effect of an intravenous nonnarcotic pain medication on common side effects\n      seen in patients taking other intravenous narcotic pain medication in the neurocritical care\n      unit."
        }, 
        "brief_title": "Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit", 
        "condition": [
            "Post-operative Craniotomy Patients", 
            "Carotid Endarterectomy and Carotid Artery Stenosis Patients", 
            "Post-op Spine Patients Admitted to the NCCU", 
            "Endovascular Patients Undergoing Intracranial Intervention", 
            "Traumatic Brain Injuries NPO for at Least 12 Hours"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carotid Stenosis", 
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  > 45 kg (amenable to adult dosing)\n\n          -  all traumatic brain injuries NPO for at least 12 hours\n\n          -  all post-operative craniotomy patients\n\n          -  all non-operative subarachnoid hemorrhage, intraparenchymal hemorrhage, and stroke\n             patients\n\n          -  all carotid endarterectomy and carotid artery stenosis patients\n\n          -  all endovascular patients undergoing intracranial intervention\n\n          -  all post-op spine patients admitted to the NCCU\n\n        Exclusion Criteria:\n\n          -  documented allergy to acetaminophen\n\n          -  documented severe hepatic impairment (Child-Pugh score > 6) or severe hepatic disease\n             (hepatitis)\n\n          -  documented severe renal impairment (CrCl < 30 ml/min) Blood tests will be performed\n             prior to study procedures that will ensure patients do not have renal impairment.\n\n          -  patients who are pregnant or breast feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948505", 
            "org_study_id": "00061838"
        }, 
        "intervention": [
            {
                "arm_group_label": "Intervention group", 
                "intervention_name": "Intravenous acetaminophen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo Group", 
                "intervention_name": "Placebo for IV acetaminophen", 
                "intervention_type": "Drug", 
                "other_name": "Normal Saline"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "Craniotomy", 
        "lastchanged_date": "September 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Salt Lake City", 
                    "country": "United States", 
                    "state": "Utah", 
                    "zip": "84132"
                }, 
                "name": "University of Utah"
            }, 
            "investigator": {
                "last_name": "Walavan Sivakumar, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "Frequency of nausea, vomiting, urinary retention & constipation", 
            "safety_issue": "No", 
            "time_frame": "48 hours"
        }, 
        "overall_contact": {
            "email": "walavan.sivakumar@hsc.utah.edu", 
            "last_name": "Walavan Sivakumar, MD", 
            "phone": "818-599-3570"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Level of pain as measured on the 0-10 Numeric Rating Scale (NRS)", 
            "safety_issue": "No", 
            "time_frame": "48 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948505"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Utah", 
            "investigator_full_name": "Walavan Sivakumar", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Sedation level as measured on the Riker Scale (1-7)", 
            "safety_issue": "No", 
            "time_frame": "48 hours"
        }, 
        "source": "University of Utah", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Utah", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}